Özgecan Dülgar Kaya
10PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Apr 08, 2026
Determinants of survival after neoadjuvant chemotherapy in resectable gastric cancer: adjuvant dose intensity, radiotherapy, and pathologic response.Özgecan Dülgar Kaya, Ayberk Bayramgil, Ahmet Bilici
|May 20, 2025
Extraordinary Benefit of Regorafenib in Metastatic Cholangiocarcinoma: A Case Report.Ayberk Bayramgil, Tugce Kubra Gunes, Fatma Gulcicek Ayranci
|Jun 21, 2024
Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study.Özgecan Dülgar, Sema Türker, Gül Başaran
|Mar 18, 2024
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study.Hasan Cagri Yildirim, Caner Kapar, Baris Koksal
|May 17, 2022
Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study.Tuğba Başoğlu, Abdullah Sakin, Cihan Erol
|May 11, 2022
Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?Özgecan Dülgar, Başak Bala Öven, Muhammed Mustafa Atcı
Pageof 2
Frequent Collaborators
4 joint publications
Deniz Tataroğlu Özyükseler
3 joint publications
Seval Ay
2 joint publications
Hasan Çağrı Yıldırım
2 joint publications
Muhammed Mustafa Atcı
2 joint publications
Rukiye Arıkan
2 joint publications
Mahmut Gümüş
2 joint publications
Başak Bala Öven
1 joint publications
Deniz Tural
1 joint publications
Melike Ozcelik
1 joint publications
Nail Paksoy
